Glucagon-like peptide-1: difference between revisions
Diff·revision 17 → 18·21:19, 24 Jan 2025
Difference between revision 17 and revision 18 of Glucagon-like peptide-1. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 17 — 20:43, 5 Jan 2025 EmptyingElke (talk) clarify that concentrations differ substantially between assay platforms 10,017 bytes +73 | Revision 18 — 21:19, 24 Jan 2025 BetaCellBoyd (talk) clarify that the incretin effect is defined by the oral–intravenous comparison 10,017 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |